H. Deicher

522 total citations
26 papers, 336 citations indexed

About

H. Deicher is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, H. Deicher has authored 26 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 9 papers in Immunology and 6 papers in Genetics. Recurrent topics in H. Deicher's work include Blood disorders and treatments (5 papers), Blood groups and transfusion (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). H. Deicher is often cited by papers focused on Blood disorders and treatments (5 papers), Blood groups and transfusion (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). H. Deicher collaborates with scholars based in Germany, Switzerland and Sweden. H. Deicher's co-authors include Peter von Wussow, D Jakschies, Mathias Freund, Michel A. Horisberger, H. K. Hochkeppel, Hartmut Link, H. Poliwoda, H. Wilke, H. Diedrich and Frank Buchholz and has published in prestigious journals such as Cancer, AIDS and British Journal of Haematology.

In The Last Decade

H. Deicher

23 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Deicher Germany 10 111 87 66 60 57 26 336
Malcolm M. Hargraves United States 7 106 1.0× 48 0.6× 126 1.9× 43 0.7× 31 0.5× 11 301
Christopher M. Bearden United States 9 165 1.5× 62 0.7× 35 0.5× 47 0.8× 51 0.9× 9 504
V. Lenhard Germany 9 92 0.8× 104 1.2× 16 0.2× 67 1.1× 25 0.4× 30 373
Jean‐Marc Doutrelepont Belgium 11 241 2.2× 105 1.2× 66 1.0× 20 0.3× 19 0.3× 18 451
A Zlotnick Israel 12 64 0.6× 42 0.5× 87 1.3× 34 0.6× 48 0.8× 37 371
Seiji Fujioka Japan 8 49 0.4× 34 0.4× 39 0.6× 51 0.8× 20 0.4× 15 523
Laurent Gilardin France 11 179 1.6× 98 1.1× 44 0.7× 33 0.6× 44 0.8× 27 454
É Gyódi Hungary 13 202 1.8× 79 0.9× 82 1.2× 70 1.2× 26 0.5× 52 396
M. E. C. Jeurissen Netherlands 9 40 0.4× 114 1.3× 226 3.4× 42 0.7× 69 1.2× 12 420
W Schneider Germany 10 56 0.5× 176 2.0× 23 0.3× 18 0.3× 36 0.6× 43 421

Countries citing papers authored by H. Deicher

Since Specialization
Citations

This map shows the geographic impact of H. Deicher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Deicher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Deicher more than expected).

Fields of papers citing papers by H. Deicher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Deicher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Deicher. The network helps show where H. Deicher may publish in the future.

Co-authorship network of co-authors of H. Deicher

This figure shows the co-authorship network connecting the top 25 collaborators of H. Deicher. A scholar is included among the top collaborators of H. Deicher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Deicher. H. Deicher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoppe, Gabriela, K. Wildhagen, Henry G. Kunkel, & H. Deicher. (2008). Zentralnervöse Beteiligung bei systemischem Lupus erythematodes. DMW - Deutsche Medizinische Wochenschrift. 115(11). 426–431.
2.
Hartmann, Frank, et al.. (2008). Psoriasis-Exazerbation bei Therapie mit α-Interferon. DMW - Deutsche Medizinische Wochenschrift. 114(3). 96–98. 6 indexed citations
3.
Witte, T, et al.. (1996). Autoantibody against a 58 kD molecule in a patient with neutropenia and NK cell deficiency. British Journal of Haematology. 92(3). 565–570.
4.
Wussow, Peter von, R. Hehlmann, D Jakschies, et al.. (1994). Roferon (rIFN-α 2a ) Is More Immunogenic Than Intron A (rIFN-α 2b ) in Patients with Chronic Myelogenous Leukemia. Journal of Interferon Research. 14(4). 217–219. 24 indexed citations
5.
Süttmann, U., Donald C. McMillan, Andreas Melzer, et al.. (1993). Nitrogen balance in HIV-infected patients during total parenteral nutrition. Clinical Nutrition. 12. 44–44. 1 indexed citations
6.
Brunkhorst, R., et al.. (1992). Lack of clinical evidence for a specific HIV-associated glomerulopathy in 203 patients with HIV infection. Nephrology Dialysis Transplantation. 7(2). 87–92. 4 indexed citations
7.
Wussow, Peter von, D Jakschies, M. Freund, et al.. (1991). Treatment of anti‐recombinant interferon‐alpha 2 antibody positive CML patients with natural interferon‐alpha. British Journal of Haematology. 78(2). 210–216. 38 indexed citations
8.
Stoll, Matthias, Mathias Freund, Hansjörg Schmid, et al.. (1990). Allogeneic bone marrow transplantation for Langerhans' cell histiocytosis. Cancer. 66(2). 284–288. 38 indexed citations
9.
Wussow, Peter von, D Jakschies, I. Schedel, et al.. (1990). The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. AIDS. 4(2). 119–124. 33 indexed citations
10.
Freund, Mathias, Peter von Wussow, H. Diedrich, et al.. (1989). Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodies. British Journal of Haematology. 72(3). 350–356. 75 indexed citations
11.
Wussow, Peter von, D Jakschies, Mathias Freund, & H. Deicher. (1989). Humoral response to recombinant interferon-alpha 2b in patients receiving recombinant interferon-alpha 2b therapy.. PubMed. 9 Suppl 1. S25–31. 14 indexed citations
12.
Alexander, J. Wesley, S Barandun, H. Deicher, et al.. (1979). Which Is the Factual Basis, in Theory and Clinical Practice,for the Use of Intravenous Gammaglobulin in the Treatment ofSevere Bacterial Infections?. Vox Sanguinis. 37(2). 116–128. 12 indexed citations
13.
Deicher, H., et al.. (1976). [Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion (author's transl)].. PubMed. 36(6). 485–92. 1 indexed citations
14.
Deicher, H.. (1972). [Acquired antibody-deficiency syndromes].. PubMed. 23(36). 1197–9.
15.
Deicher, H., et al.. (1971). [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].. PubMed. 31(10). 911–23. 3 indexed citations
16.
Hartmann, Wolfgang, et al.. (1971). Acute kidney failure due to immunohaemolytic anaemia following consumption of P. involutus.. DMW - Deutsche Medizinische Wochenschrift. 96(28). 1188–1191. 1 indexed citations
17.
Deicher, H., et al.. (1970). [Suppression of transplantation reaction by a new nitrogen mustard compound, 3-(2-chlorethyl)-2-(2-chlorethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide].. PubMed. 20(4). 588–9. 1 indexed citations
18.
Deicher, H., et al.. (1969). [Prevention of sensitization by means of intravenous administration of Anti-D immunoglobulin G. I. Clinical results and studies of Anti-D dosage].. PubMed. 29(3). 203–12. 8 indexed citations
19.
Schneider, Jochen, William Pollack, H. Deicher, et al.. (1969). Arbeitskreis 8 Die Prophylaxe der Rh-Sensibilisierung. Archives of Gynecology and Obstetrics. 207(1-2). 410–416. 14 indexed citations
20.
Deicher, H., et al.. (1966). Kveim-Test und Sarkoidose. Archives of Dermatological Research. 227(1). 113–115. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malcolm M. Hargraves Breakdown of academic impact, for papers by Christopher M. Bearden Breakdown of academic impact, for papers by V. Lenhard Breakdown of academic impact, for papers by Jean‐Marc Doutrelepont Breakdown of academic impact, for papers by A Zlotnick Breakdown of academic impact, for papers by Seiji Fujioka Breakdown of academic impact, for papers by Laurent Gilardin Breakdown of academic impact, for papers by É Gyódi Breakdown of academic impact, for papers by M. E. C. Jeurissen Breakdown of academic impact, for papers by W Schneider
Rankless by CCL
2026